MoneyWorks4Me

Marksans Pharma - Quaterly Results

11 Feb 2022 Evaluate
Revenue reduced marginally to stand at Rs. 1659.37 millions during the quarter ended December 2021. The figure stood at Rs. 1684.55 millions during the year-ago period.The Net Profit of the company registered a slight decline of -10.46% to Rs. 260.57  millions from Rs. 291.02 millions.A decline of 398.85 millions was observed in the OP in the quarter ended December 2021 from 411.23 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1659.37 1684.55 -1.49 4820.11 4619.66 4.34 5995.48 4334.15 38.33
Other Income 120.65 62.41 93.32 346.03 192.47 79.78 311.56 1.73 17909.25
PBIDT 398.85 411.23 -3.01 1214.49 1061.79 14.38 1448.68 716.63 102.15
Interest 6.85 10.98 -37.61 25.17 32.07 -21.52 53.45 72.92 -26.70
PBDT 392.00 400.25 -2.06 1189.32 1029.72 15.50 1395.23 643.71 116.75
Depreciation 45.21 40.34 12.07 130.54 110.48 18.16 151.93 116.44 30.48
PBT 346.79 359.91 -3.65 1058.78 919.24 15.18 1243.30 527.27 135.80
TAX 86.22 68.89 25.16 233.18 172.32 35.32 259.49 148.24 75.05
Deferred Tax 1.22 -10.10 -112.08 16.30 -32.97 -149.44 -22.39 36.77 -160.89
PAT 260.57 291.02 -10.46 825.60 746.92 10.53 983.81 379.03 159.56
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 24.04 24.41 -1.54 25.20 22.98 9.62 24.16 16.53 46.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..